tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

OCS Stock Latest News

Oculis price target raised to $31 from $23 at BofA
The FlyOculis price target raised to $31 from $23 at BofA
24d ago
OCS
Oculis Holding’s OCS-05 Shows Promising Results in Phase 2 Trial for Acute Optic Neuritis
PremiumCompany Announcements
Oculis Holding’s OCS-05 Shows Promising Results in Phase 2 Trial for Acute Optic Neuritis
24d ago
6K
OCS
Oculis Holding (OCS): A Biopharma Opportunity for Adventurous Investors
PremiumMarket News
Oculis Holding (OCS): A Biopharma Opportunity for Adventurous Investors
1M ago
OCS
Oculis Holding AG Reports Q3 2024 Financial Progress
PremiumCompany Announcements
Oculis Holding AG Reports Q3 2024 Financial Progress
3M ago
OCS
Oculis Holding’s Financial Struggles Amid Asset Growth
PremiumCompany Announcements
Oculis Holding’s Financial Struggles Amid Asset Growth
3M ago
6K
OCS
Oculis Holding Ag (OCS) Q3 Earnings Cheat Sheet
PremiumPre-EarningsOculis Holding Ag (OCS) Q3 Earnings Cheat Sheet
3M ago
OCS
Oculis accelerates patient enrollment for both Phase 3 DIAMOND trials
Premium
The Fly
Oculis accelerates patient enrollment for both Phase 3 DIAMOND trials
3M ago
OCS
Oculis files to sell 361,011 ordinary shares for holders
Premium
The Fly
Oculis files to sell 361,011 ordinary shares for holders
5M ago
OCS
Oculis Holding Shows Strong Asset and Equity Growth
PremiumCompany Announcements
Oculis Holding Shows Strong Asset and Equity Growth
5M ago
6K
OCS
Oculis appoints Sharon Klier as CDO
PremiumThe Fly
Oculis appoints Sharon Klier as CDO
6M ago
OCS
OCS Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
OCS Upcoming Earnings Report: What to Expect?
6M ago
OCS
Oculis’ (OCS) Stock Moves Sideways Amid Growing Anticipation
PremiumMarket News
Oculis’ (OCS) Stock Moves Sideways Amid Growing Anticipation
6M ago
OCS
Oculis price target lowered to $20 from $21 at BofA
PremiumThe FlyOculis price target lowered to $20 from $21 at BofA
8M ago
OCS
Oculis price target raised to $30 from $28 at H.C. Wainwright
Premium
The Fly
Oculis price target raised to $30 from $28 at H.C. Wainwright
8M ago
OCS
Oculis Announces Breakthrough in DED Treatment
Premium
Company Announcements
Oculis Announces Breakthrough in DED Treatment
8M ago
6K
OCS
Oculis price target raised to $37 from $35 at Baird
PremiumThe Fly
Oculis price target raised to $37 from $35 at Baird
8M ago
OCS
Oculis Holding AG Bolsters Leadership and Capital
PremiumCompany Announcements
Oculis Holding AG Bolsters Leadership and Capital
8M ago
6K
OCS
Oculis price target lowered to $28 from $29 at H.C. Wainwright
PremiumThe Fly
Oculis price target lowered to $28 from $29 at H.C. Wainwright
9M ago
OCS
Oculis announces listing on Nasdaq Iceland Main Market
PremiumThe Fly
Oculis announces listing on Nasdaq Iceland Main Market
10M ago
OCS
Oculis names Dr. Snehal Shah as President of Research & Development
PremiumThe FlyOculis names Dr. Snehal Shah as President of Research & Development
10M ago
OCS
Oculis announces ‘positive’ results from Phase 3 OPTIMIZE-1 trial of OCS-01
Premium
The Fly
Oculis announces ‘positive’ results from Phase 3 OPTIMIZE-1 trial of OCS-01
10M ago
OCS
Oculis announces ‘positive’ results from Phase 3 OPTIMIZE-1 trial of OCS-01
Premium
The Fly
Oculis announces ‘positive’ results from Phase 3 OPTIMIZE-1 trial of OCS-01
10M ago
OCS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >